+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global GI Stool Testing Market by Product (Analyzers, Consumables), Test (Bacteria Test, Fecal Biomarkers Test, Occult Blood Test), Application, End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977951
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The GI Stool Testing Market size was estimated at USD 651.69 million in 2023, USD 691.83 million in 2024, and is expected to grow at a CAGR of 6.67% to reachUSD 1.02 billion by 2030.

Rising cases of diseases such as colorectal cancer, IBD, and infections increase the demand for effective diagnostic methods. Technological innovations in testing technologies enhance the accuracy and speed of test results, appealing to both healthcare providers and patients. Increased health awareness and an improved understanding of the importance of early diagnosis contribute to market growth. However, stringent regulations governing diagnostic testing can delay product launches and influence market dynamics. Lack of healthcare infrastructure may challenge market growth in lesser-developed regions. Moreover, the detection of genetic markers in fecal samples can offer substantial growth opportunities. Leveraging artificial intelligence and machine learning for better data analysis and result accuracy presents a significant opportunity for market expansion.

Regional Insights

In the Americas region, particularly in the United States and Canada, the prevalence of gastrointestinal disorders such as IBS, Crohn's disease, and colorectal cancer has significantly driven the demand for GI stool testing. High awareness about health and preventive care, comprehensive insurance coverage, and robust healthcare infrastructure contribute to the sophistication of the GI stool testing market. EU countries exhibit a strong market for GI stool tests owing to high healthcare standards and prevalent screening programs for colorectal cancer. Countries such as France, Germany, and the UK emphasize preventative healthcare, thereby facilitating substantial market growth in this region. Middle East countries such as Saudi Arabia and UAE are rapidly adopting modern healthcare practices, including the use of sophisticated diagnostics tools for GI disorders. However, in parts of Africa, limited healthcare infrastructure and lower health literacy levels constrain the market. In the Asia-Pacific region, China's rapidly growing healthcare sector, bolstered by governmental reforms aimed at improving healthcare access, presents significant opportunities for the GI stool testing market. Aging population dynamics invite higher incidences of gastrointestinal illnesses, further strengthening the market scope in Japan. India's market is nascent but growing rapidly, driven by increasing awareness and improving healthcare infrastructure.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the GI Stool Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising incidences of gastrointestinal disorders and diseases across the world
  • Efforts by governments and foundations to raise awareness for gastrointestinal health

Market Restraints

  • Issues associated with product recalls in GI stool testing

Market Opportunities

  • Technological advancements in GI stool testing methods to develop more accurate and less invasive tools
  • Reforms and supportive measures in healthcare policies

Market Challenges

  • Challenges with product standardization and compatibility

Market Segmentation Analysis

  • Product: Preference towards GI stool analyzers due to their speed and accuracy in diagnostics
  • End-Users: Expanding application of GI Stool Testing in diagnostic centers

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the GI Stool Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the GI Stool Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

FDA Approval of ColoSense, A Breakthrough in Noninvasive Colorectal Cancer Screening

Geneoscopy, Inc., an innovator in gastrointestinal health diagnostics, announced FDA approval for its groundbreaking colorectal cancer (CRC) screening test, ColoSense. Suitable for adults aged 45 and older at average CRC risk, ColoSense stands out as the first noninvasive test employing RNA biomarkers to dynamically assess disease activity without the variability seen in other age-dependent tests. This approval followed the impressive results of the CRC-PREVENT trial, which showed ColoSense's high sensitivity for detecting CRC and 100% in early-stage detection, where the disease is highly treatable.

Evaluation of ColoTest, A Consumer-Friendly, At-Home Screening Tool for Early Detection of Gastrointestinal Conditions

ColoTest, an over-the-counter immunochemical fecal occult blood test, is marketed by Reese Pharmaceutical for at-home use. This kit is designed to detect hidden blood in stool, indicative of serious conditions such as colorectal cancer and gastrointestinal disorders, providing a test cassette, sample collection tube, and necessary instructions for user convenience.

Geneoscopy and Labcorp Partnership Elevates Access to Innovative Colorectal Cancer Screening

Geneoscopy Inc., has announced a strategic partnership with Labcorp for distribution of Geneoscopy’s revolutionary at-home colorectal cancer (CRC) screening test, which is awaiting FDA approval. Upon approval, the test will be available through Labcorp, bolstering the convenience and accessibility of CRC screening. The test utilizes a multi-target stool RNA biomarker panel, capable of identifying both precancerous lesions and colorectal cancer, showing high sensitivity in clinical trials.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the GI Stool Testing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the GI Stool Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, Cardinal Health, Cenogenics Corporation, CTK Biotech, Inc., Danaher Corporation, Diagnostic Solutions Laboratory, LLC, DiaSorin S.p.A., Eiken Chemical Co., Ltd., Emes Software, LLC, Epitope Diagnostics Inc., Geisinger Medical Laboratories, Genova Diagnostics Inc., Helena Laboratories Corporation, Hologic Inc., Lauriston Laboratories Ltd, Meridian Bioscience Inc., Pinnacle BioLabs, Polymedco, LLC, Quest Diagnostics, QuidelOrtho Corporation, ScheBo Biotech AG, and Siemens Healthineers.

Market Segmentation & Coverage

This research report categorizes the GI Stool Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Analyzers
  • Consumables

Test

  • Bacteria Test

Fecal Biomarkers Test

  • Transferrin Assays
  • Tumor M2-PK Stool Test

Occult Blood Test

  • Guaiac FOB Stool Test
  • Immuno FOB Agglutination Test
  • Immuno FOB ELISA Test
  • Lateral Flow Immuno FOB Test
  • Ova and Parasites Test

Application

  • Cancer
  • Gastroesophageal Reflux Disease
  • Infection
  • Inflammatory Bowel Disease

End-use

  • Diagnostic Centers
  • Homecare Settings
  • Hospitals & Clinics

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of gastrointestinal disorders and diseases across the world
5.1.1.2. Efforts by governments and foundations to raise awareness for gastrointestinal health
5.1.2. Restraints
5.1.2.1. Issues associated with product recalls in GI stool testing
5.1.3. Opportunities
5.1.3.1. Technological advancements in GI stool testing methods to develop more accurate and less invasive tools
5.1.3.2. Reforms and supportive measures in healthcare policies
5.1.4. Challenges
5.1.4.1. Challenges with product standardization and compatibility
5.2. Market Segmentation Analysis
5.2.1. Product: Preference towards GI stool analyzers due to their speed and accuracy in diagnostics
5.2.2. End-Users: Expanding application of GI Stool Testing in diagnostic centers
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. GI Stool Testing Market, by Product
6.1. Introduction
6.2. Analyzers
6.3. Consumables
7. GI Stool Testing Market, by Test
7.1. Introduction
7.2. Bacteria Test
7.3. Fecal Biomarkers Test
7.4. Occult Blood Test
7.5. Ova and Parasites Test
8. GI Stool Testing Market, by Application
8.1. Introduction
8.2. Cancer
8.3. Gastroesophageal Reflux Disease
8.4. Infection
8.5. Inflammatory Bowel Disease
9. GI Stool Testing Market, by End-use
9.1. Introduction
9.2. Diagnostic Centers
9.3. Homecare Settings
9.4. Hospitals & Clinics
10. Americas GI Stool Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific GI Stool Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa GI Stool Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. FDA Approval of ColoSense, A Breakthrough in Noninvasive Colorectal Cancer Screening
13.3.2. Evaluation of ColoTest, A Consumer-Friendly, At-Home Screening Tool for Early Detection of Gastrointestinal Conditions
13.3.3. Geneoscopy and Labcorp Partnership Elevates Access to Innovative Colorectal Cancer Screening
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. GI STOOL TESTING MARKET RESEARCH PROCESS
FIGURE 2. GI STOOL TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GI STOOL TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2023 VS 2030 (%)
FIGURE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. GI STOOL TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. GI STOOL TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GI STOOL TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL GI STOOL TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL GI STOOL TESTING MARKET SIZE, BY BACTERIA TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL GI STOOL TESTING MARKET SIZE, BY BACTERIA TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL GI STOOL TESTING MARKET SIZE, BY TRANSFERRIN ASSAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL GI STOOL TESTING MARKET SIZE, BY TRANSFERRIN ASSAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL GI STOOL TESTING MARKET SIZE, BY TUMOR M2-PK STOOL TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL GI STOOL TESTING MARKET SIZE, BY TUMOR M2-PK STOOL TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL GI STOOL TESTING MARKET SIZE, BY GUAIAC FOB STOOL TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL GI STOOL TESTING MARKET SIZE, BY GUAIAC FOB STOOL TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB AGGLUTINATION TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB AGGLUTINATION TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB ELISA TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB ELISA TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW IMMUNO FOB TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW IMMUNO FOB TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL GI STOOL TESTING MARKET SIZE, BY OVA AND PARASITES TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL GI STOOL TESTING MARKET SIZE, BY OVA AND PARASITES TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL GI STOOL TESTING MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL GI STOOL TESTING MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 95. CANADA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. CANADA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. CANADA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 98. CANADA GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 99. CANADA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 100. CANADA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 101. CANADA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 102. CANADA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 103. CANADA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. CANADA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. CANADA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 106. CANADA GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 107. MEXICO GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. MEXICO GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. MEXICO GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 110. MEXICO GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 111. MEXICO GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 112. MEXICO GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 113. MEXICO GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 114. MEXICO GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 115. MEXICO GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. MEXICO GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. MEXICO GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 118. MEXICO GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 127. UNITED STATES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. UNITED STATES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. UNITED STATES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 130. UNITED STATES GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 144. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 146. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 147. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 150. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 151. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 152. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 153. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 154. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 155. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 158. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 159. CHINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 160. CHINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 161. CHINA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 162. CHINA GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 163. CHINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 164. CHINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 165. CHINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 166. CHINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 167. CHINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. CHINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. CHINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 170. CHINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 171. INDIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. INDIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. INDIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 174. INDIA GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 175. INDIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 176. INDIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 177. INDIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 178. INDIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 179. INDIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. INDIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. INDIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 182. INDIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 183. INDONESIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. INDONESIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. INDONESIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 186. INDONESIA GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 187. INDONESIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 188. INDONESIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 189. INDONESIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 190. INDONESIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 191. INDONESIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. INDONESIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. INDONESIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 194. INDONESIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 195. JAPAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. JAPAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. JAPAN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 198. JAPAN GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 199. JAPAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 200. JAPAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 201. JAPAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 202. JAPAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 203. JAPAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. JAPAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. JAPAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 206. JAPAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 207. MALAYSIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 208. MALAYSIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 209. MALAYSIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 210. MALAYSIA GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 211. MALAYSIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 212. MALAYSIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 213. MALAYSIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 214. MALAYSIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 215. MALAYSIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. MALAYSIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. MALAYSIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 218. MALAYSIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 219. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 220. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 221. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 222. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 223. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 224. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 225. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 226. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 227. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 230. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 231. SINGAPORE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. SINGAPORE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. SINGAPORE GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 234. SINGAPORE GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 235. SINGAPORE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 236. SINGAPORE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 237. SINGAPORE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 238. SINGAPORE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 239. SINGAPORE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. SINGAPORE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. SINGAPORE GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 242. SINGAPORE GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 243. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 244. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 245. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 246. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 247. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 248. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 249. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 250. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 251. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 254. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 255. TAIWAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 256. TAIWAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 257. TAIWAN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 258. TAIWAN GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 259. TAIWAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 260. TAIWAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 261. TAIWAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 262. TAIWAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 263. TAIWAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. TAIWAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. TAIWAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 266. TAIWAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 267. THAILAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 268. THAILAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 269. THAILAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 270. THAILAND GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 271. THAILAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 272. THAILAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 273. THAILAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 274. THAILAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 275. THAILAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. THAILAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. THAILAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 278. THAILAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 279. VIETNAM GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 280. VIETNAM GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 281. VIETNAM GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 282. VIETNAM GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 283. VIETNAM GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 284. VIETNAM GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 285. VIETNAM GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 286. VIETNAM GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 287. VIETNAM GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. VIETNAM GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. VIETNAM GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 290. VIETNAM GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 305. DENMARK GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 306. DENMARK GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 307. DENMARK GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 308. DENMARK GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 309. DENMARK GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 310. DENMARK GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 311. DENMARK GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 312. DENMARK GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 313. DENMARK GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 314. DENMARK GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 315. DENMARK GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 316. DENMARK GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 317. EGYPT GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 318. EGYPT GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 319. EGYPT GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 320. EGYPT GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 321. EGYPT GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 322. EGYPT GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 323. EGYPT GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 324. EGYPT GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 325. EGYPT GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 326. EGYPT GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 327. EGYPT GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 328. EGYPT GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 329. FINLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 330. FINLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 331. FINLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 332. FINLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 333. FINLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 334. FINLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 335. FINLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 336. FINLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 337. FINLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 338. FINLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 339. FINLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 340. FINLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 341. FRANCE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 342. FRANCE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 343. FRANCE GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 344. FRANCE GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 345. FRANCE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 346. FRANCE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2024-2030 (USD MILLION)
TABLE 347. FRANCE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2023 (USD MILLION)
TABLE 348. FRANCE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2024-2030 (USD MILLION)
TABLE 349. FRANCE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 350. FRANCE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 351. FRANCE GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 352. FRANCE GI STOOL TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 353. GERMANY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 354. GERMANY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 355. GERMANY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2023 (USD MILLION)
TABLE 356. GERMANY GI STOOL TESTING MARKET SIZE, BY TEST, 2024-2030 (USD MILLION)
TABLE 357. GERMANY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2023 (USD MILLION)
TABLE 358. GERMANY

Companies Mentioned

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Cardinal Health
  • Cenogenics Corporation
  • CTK Biotech, Inc.
  • Danaher Corporation
  • Diagnostic Solutions Laboratory, LLC
  • DiaSorin S.p.A.
  • Eiken Chemical Co., Ltd.
  • Emes Software, LLC
  • Epitope Diagnostics Inc.
  • Geisinger Medical Laboratories
  • Genova Diagnostics Inc.
  • Helena Laboratories Corporation
  • Hologic Inc.
  • Lauriston Laboratories Ltd
  • Meridian Bioscience Inc.
  • Pinnacle BioLabs
  • Polymedco, LLC
  • Quest Diagnostics
  • QuidelOrtho Corporation
  • ScheBo Biotech AG
  • Siemens Healthineers

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 691.83 Million
Forecasted Market Value ( USD ) by 2030 $ 1024.26 Million
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

GI Stool Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

GI Stool Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 117 Pages
  • Global
From
Global Stool Testing Market 2024-2028 - Product Image

Global Stool Testing Market 2024-2028

  • Report
  • 165 Pages
  • Global
From
GI Stool Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

GI Stool Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 96 Pages
  • Global
From
In-vitro Colorectal Cancer Screening Tests Market Size, Share & Trends Analysis Report By Test Type (Fecal Occult Blood Tests, Biomarker Tests, CRC DNA Screening Tests), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

In-vitro Colorectal Cancer Screening Tests Market Size, Share & Trends Analysis Report By Test Type (Fecal Occult Blood Tests, Biomarker Tests, CRC DNA Screening Tests), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 129 Pages
  • Global
From
Italy 2024 Home/Self-Testing Market: Diabetes, Pregnancy, Ovulation, Occult Blood - Sales Forecasts, Technology Trends, Competitive Strategies - Product Image

Italy 2024 Home/Self-Testing Market: Diabetes, Pregnancy, Ovulation, Occult Blood - Sales Forecasts, Technology Trends, Competitive Strategies

  • Report
  • 175 Pages
  • Italy
From

About the GI Stool Test Market

The GI Stool Test market within the context of In Vitro Diagnostics is a segment of the medical diagnostics industry that focuses on the detection of gastrointestinal diseases and disorders. It is a rapidly growing market, driven by the increasing prevalence of gastrointestinal diseases and the need for early diagnosis and treatment. GI Stool Tests are used to detect a variety of gastrointestinal conditions, including bacterial infections, parasites, and inflammatory bowel disease. These tests are typically performed in a laboratory setting and can provide valuable information to healthcare providers. The GI Stool Test market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Quest Diagnostics, LabCorp, Bio-Rad Laboratories, and Genova Diagnostics. Other companies in the market include Eurofins Scientific, Mayo Medical Laboratories, and ARUP Laboratories. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.